<?xml version="1.0" encoding="UTF-8"?>
<ref id="b8-1031835">
 <label>8.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mahon</surname>
    <given-names>FX</given-names>
   </name>
   <name>
    <surname>Rea</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Guilhot</surname>
    <given-names>J</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial</article-title>. 
  <source>Lancet Oncol</source>. 
  <year>2010</year>;
  <volume>11</volume>(
  <issue>11</issue>):
  <fpage>1029</fpage>â€“
  <lpage>1035</lpage>.
  <pub-id pub-id-type="pmid">20965785</pub-id>
 </mixed-citation>
</ref>
